MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,324 | -59.6% | 31,751 | +4.7% | 0.00% | – |
| Q2 2023 | $99,816 | -4.6% | 30,339 | +19.2% | 0.00% | – |
| Q1 2023 | $104,649 | -18.3% | 25,462 | +16.4% | 0.00% | – |
| Q4 2022 | $128,141 | +0.1% | 21,867 | +15.6% | 0.00% | – |
| Q3 2022 | $128,000 | +100.0% | 18,920 | +35.7% | 0.00% | – |
| Q2 2022 | $64,000 | +42.2% | 13,938 | +24.8% | 0.00% | – |
| Q1 2022 | $45,000 | -30.8% | 11,169 | +6.3% | 0.00% | – |
| Q4 2021 | $65,000 | -73.5% | 10,511 | -59.6% | 0.00% | – |
| Q3 2021 | $245,000 | -30.6% | 26,013 | -0.1% | 0.00% | – |
| Q2 2021 | $353,000 | -73.1% | 26,040 | -67.9% | 0.00% | -100.0% |
| Q1 2021 | $1,313,000 | -36.6% | 81,156 | +4.3% | 0.00% | -50.0% |
| Q4 2020 | $2,070,000 | – | 77,783 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
| Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
| Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
| Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
| Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
| Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
| Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
| DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |